Abstract

Introduction and objectives: Jorge Lobo’s disease is a rare chronic disease caused by the fungus Lacazia loboi, characterized by keloid lesions on the skin. The objective is to perform a review of the literature and report the first case of Jorge Lobo’s disease treated at the University Hospital Cassiano Antônio Moraes (HUCAM). Materials and methods: The study data were obtained retrospectively from the analysis and systematic review of the medical records of a patient with Jorge Lobo’s diseaseidentified in HUCAM. Case Report: A male patient aged 37 years was referred to HUCAM in April 2010 presenting with keloid lesions and a previous diagnosis of lobomycosis by histopathology examination. On December 2011 a partial removal of the lesions with grafting was performed. Three months later, there was recurrence of lobomycosis on the grafted tissue. In June 2012 drug treatment with clofazimine associated with fluconazole was started. The lack of satisfactory clinical responseafter two months meant that the disease was considered beyond cure. Discussion and literature review: lobomycosis is an endemic disease in the brazilian Amazon and other humid tropical areas of Central and South America, and its transmission occurs by inoculation of the fungus through breaks in the skin. Diagnosis is made by clinical examination and histopathologiy or cytology The choice of therapy varies with the extent of lesions. However, none of the therapies described in the literature is fully effective. Conclusion: In this case, the two main therapeutic approaches failed, andthe disease was considered incurable.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.